|
|
|
Volumn 9, Issue 2 SUPPL. 1, 1999, Pages 4-11
|
|
Role of p53 and p16 gene alterations in determining response to concurrent paclitaxel and radiation in solid tumors
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYCLIN D;
CYCLIN DEPENDENT KINASE;
DNA;
FLUOROURACIL;
FOLINIC ACID;
GENE PRODUCT;
MESSENGER RNA;
PACLITAXEL;
PLATINUM;
PROTEIN P16;
PROTEIN P21;
PROTEIN P53;
PURINE DERIVATIVE;
RETINOBLASTOMA PROTEIN;
APOPTOSIS;
CELL CYCLE;
CLINICAL TRIAL;
DNA DAMAGE;
GENE;
GENE MUTATION;
HUMAN;
LUNG NON SMALL CELL CANCER;
PANCREAS CANCER;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
RADIOSENSITIZATION;
REVIEW;
SINGLE STRAND CONFORMATION POLYMORPHISM;
SOLID TUMOR;
STOMACH CANCER;
TUMOR SUPPRESSOR GENE;
ANIMALS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
APOPTOSIS;
CARCINOMA, NON-SMALL-CELL LUNG;
CELL CYCLE;
COMBINED MODALITY THERAPY;
GENES, CDC;
GENES, P16;
GENES, P53;
HUMANS;
LUNG NEOPLASMS;
MUTATION;
PACLITAXEL;
PANCREATIC NEOPLASMS;
RADIATION-SENSITIZING AGENTS;
STOMACH NEOPLASMS;
|
|
EID: 0032948876
PISSN: 10534296
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (25)
|
|
References (58)
|
